Go Pro

Scotiabank Increases Great-West Lifeco (TSE:GWO) Price Target to C$95.00

Great-West Lifeco logo with Financial Services background
Image from MarketBeat Media, LLC.

Key Points

  • Scotiabank raised its price target on Great-West Lifeco to C$95.00 from C$83.00 and maintained a sector outperform rating, implying modest upside from the stock’s prior close.
  • Other major analysts also turned more bullish, with several firms lifting their targets and the overall consensus sitting at Moderate Buy with an average price target of C$80.73.
  • Great-West Lifeco’s shares were up 1.4% to C$92.55, near their 52-week high, while the company also reported quarterly EPS of C$1.37 on revenue of C$8.37 billion.
  • Five stocks to consider instead of Great-West Lifeco.

Great-West Lifeco (TSE:GWO - Get Free Report) had its price objective upped by investment analysts at Scotiabank from C$83.00 to C$95.00 in a research note issued on Wednesday,BayStreet.CA reports. The brokerage presently has a "sector outperform" rating on the stock. Scotiabank's target price would suggest a potential upside of 2.65% from the stock's previous close.

A number of other research firms have also issued reports on GWO. Canadian Imperial Bank of Commerce increased their target price on shares of Great-West Lifeco from C$81.00 to C$95.00 in a report on Wednesday. Royal Bank Of Canada upped their price objective on Great-West Lifeco from C$64.00 to C$77.00 in a research report on Friday, May 8th. TD lifted their target price on Great-West Lifeco from C$73.00 to C$80.00 and gave the company a "buy" rating in a report on Thursday, May 7th. Jefferies Financial Group boosted their target price on Great-West Lifeco from C$70.00 to C$83.00 in a research note on Friday, May 1st. Finally, Desjardins increased their price target on Great-West Lifeco from C$71.00 to C$80.00 and gave the company a "hold" rating in a research report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of C$80.73.

View Our Latest Research Report on GWO

Great-West Lifeco Trading Up 1.4%

TSE:GWO traded up C$1.30 on Wednesday, reaching C$92.55. 309,583 shares of the company's stock were exchanged, compared to its average volume of 1,679,431. The firm has a market capitalization of C$83.11 billion, a price-to-earnings ratio of 19.90, a price-to-earnings-growth ratio of 2.26 and a beta of 0.67. Great-West Lifeco has a 52-week low of C$51.40 and a 52-week high of C$92.97. The company has a quick ratio of 22.18, a current ratio of 6.57 and a debt-to-equity ratio of 29.59. The business has a fifty day moving average of C$83.70 and a 200-day moving average of C$72.03.

Great-West Lifeco (TSE:GWO - Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported C$1.37 EPS for the quarter. The business had revenue of C$8.37 billion during the quarter. Great-West Lifeco had a net margin of 12.86% and a return on equity of 15.17%. As a group, analysts expect that Great-West Lifeco will post 4.4525194 earnings per share for the current year.

Insider Activity at Great-West Lifeco

In other news, Director Mei Dong sold 39,400 shares of the company's stock in a transaction dated Monday, May 11th. The stock was sold at an average price of C$76.33, for a total transaction of C$3,007,402.00. Following the completion of the transaction, the director directly owned 2,721 shares of the company's stock, valued at approximately C$207,693.93. This represents a 93.54% decrease in their position. Also, insider Jean-Francois Poulin sold 20,000 shares of the company's stock in a transaction dated Friday, June 19th. The stock was sold at an average price of C$89.55, for a total value of C$1,791,000.00. Following the transaction, the insider directly owned 160 shares of the company's stock, valued at approximately C$14,328. This represents a 99.21% decrease in their ownership of the stock. Insiders have sold 119,200 shares of company stock valued at $9,821,888 over the last quarter. 70.70% of the stock is owned by insiders.

Great-West Lifeco Company Profile

(Get Free Report)

Great-West Lifeco is one of the three big Canadian life insurance firms. With just under half of the firm's profit and revenue in Canada, Great-West also operates in the U.S. and Europe. In Canada, Great-West provides both individual and group insurance. In the United States, Great-West operates Putnam Investments and defined-contribution recordkeeping firm Empower Retirement. In 2020, Great-West announced it would acquire Personal Capital and MassMutual's recordkeeping business. In Europe, Great-West offers life insurance, annuities, and reinsurance primarily in the U.K., Ireland, and Germany.

Featured Stories

Analyst Recommendations for Great-West Lifeco (TSE:GWO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Great-West Lifeco Right Now?

Before you consider Great-West Lifeco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Great-West Lifeco wasn't on the list.

While Great-West Lifeco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines